Molly Macklin (birmingham), MA CCC SLP/L is a
Speech-language Pathologist based in Oreana, Illinois. Molly Macklin (birmingham) is licensed to practice in Illinois (license number 146010594) and her current practice location is
400 W South St, Oreana, Illinois. She can be reached at her office (for appointments etc.) via phone at
(217) 468-2412.
NPI number for Molly Macklin (birmingham) is 1316452774 and her current mailing address is 400 W South St, Oreana, Illinois. She
does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1316452774.
Healthcare Provider's Profile
Full Name | Molly Macklin (birmingham) |
---|
Gender | Female |
---|
Speciality | Speech-language Pathologist |
---|
Location | 400 W South St, Oreana, Illinois |
---|
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
NPI Data:
- NPI Number: 1316452774
- Provider Enumeration Date: 12/07/2017
- Last Update Date: 12/07/2017
Medical Identifiers
Medical identifiers for Molly Macklin (birmingham) such as npi, medicare ID, medicare PIN, medicaid, etc.
Identifier | Type | State | Issuer |
1316452774 | NPI | - | NPPES |
Medical Taxonomies and Licenses
Taxonomy | Type | License (State) | Status |
235Z00000X | Speech-language Pathologist | 146010594 (Illinois) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Molly Macklin (birmingham) is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
Mailing Address | Practice Location Address |
Molly Macklin (birmingham), MA CCC SLP/L 400 W South St, Oreana, IL 62554-9774 Ph: () - | Molly Macklin (birmingham), MA CCC SLP/L 400 W South St, Oreana, IL 62554-9774 Ph: (217) 468-2412 |
Reviews and Comments